Cargando…

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer

Detalles Bibliográficos
Autores principales: Gerdts, Ethan, Priceman, Saul, Tilakawardane, Dileshni, Park, Anthony, Chang, Wen-Chung, Wright, Sarah, Brown, Christine E, Forman, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646040/
http://dx.doi.org/10.1186/2051-1426-3-S2-P115
_version_ 1782400909644398592
author Gerdts, Ethan
Priceman, Saul
Tilakawardane, Dileshni
Park, Anthony
Chang, Wen-Chung
Wright, Sarah
Brown, Christine E
Forman, Stephen J
author_facet Gerdts, Ethan
Priceman, Saul
Tilakawardane, Dileshni
Park, Anthony
Chang, Wen-Chung
Wright, Sarah
Brown, Christine E
Forman, Stephen J
author_sort Gerdts, Ethan
collection PubMed
description
format Online
Article
Text
id pubmed-4646040
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46460402015-11-20 Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer Gerdts, Ethan Priceman, Saul Tilakawardane, Dileshni Park, Anthony Chang, Wen-Chung Wright, Sarah Brown, Christine E Forman, Stephen J J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646040/ http://dx.doi.org/10.1186/2051-1426-3-S2-P115 Text en Copyright © 2015 Gerdts et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Gerdts, Ethan
Priceman, Saul
Tilakawardane, Dileshni
Park, Anthony
Chang, Wen-Chung
Wright, Sarah
Brown, Christine E
Forman, Stephen J
Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title_full Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title_fullStr Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title_full_unstemmed Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title_short Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
title_sort development and optimization of psca-specific car t cells for the treatment of bone metastatic prostate cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646040/
http://dx.doi.org/10.1186/2051-1426-3-S2-P115
work_keys_str_mv AT gerdtsethan developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT pricemansaul developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT tilakawardanedileshni developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT parkanthony developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT changwenchung developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT wrightsarah developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT brownchristinee developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer
AT formanstephenj developmentandoptimizationofpscaspecificcartcellsforthetreatmentofbonemetastaticprostatecancer